Vertex Pharmaceuticals
VRTX
$437.49
Share price
2.08%
Change (1 day)
25.48%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) Fails to deliver data
Key failure to deliver metrics for Vertex Pharmaceuticals:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.22 M
- Last 3 months FTD volume: $1.39 M
- Last year FTD volume: $59.49 M
Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013
Volume in USD (price x number of shares), data since 2013Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $5.87 M | -91.87% |
| 2023 | $72.22 M | -74.09% |
| 2022 | $0.27 B | -30.13% |
| 2021 | $0.39 B | 362.79% |
| 2020 | $86.19 M | -5.31% |
| 2019 | $91.02 M | 118.2% |
| 2018 | $41.71 M | -34.93% |
| 2017 | $64.1 M | 6.65% |
| 2016 | $60.11 M | -11.43% |
| 2015 | $67.86 M | 280.1% |
| 2014 | $17.85 M | 66.84% |
| 2013 | $10.7 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 AbbVie ABBV | $8.72 M | $79.91 M | 🇺🇸 USA |
 Gilead Sciences GILD | $3.99 M | $0.25 B | 🇺🇸 USA |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.19 M | $1.12 M | 🇺🇸 USA |